Failure of CHOP with rituximab for lymphomatoid granulomatosis

Netherlands Journal of Medicine

Volumn 65, Issue 11, 2007, Pages 442-447

  Oosting Lenstra, S F ^a,b   van Marwijk Kooy, M ^a  

^a ISALA HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Epstein Barr virus; Interferon; Lymphomatoid granulomatosis; Lymphoproliferative disease; Rituximab

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA2B INTERFERON; CD20 ANTIBODY; CD3 ANTIBODY; CYCLOPHOSPHAMIDE; DOXORUBICIN; GAMMA GLUTAMYLTRANSFERASE; PREDNISONE; RITUXIMAB; VINCRISTINE SULFATE;

AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANAMNESIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; EPSTEIN BARR VIRUS; ERYTHROCYTE SEDIMENTATION RATE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; LEUKOCYTOSIS; LYMPHOMATOID GRANULOMATOSIS; MALE; MICROCYTIC ANEMIA; MULTIDRUG RESISTANCE; MULTIPLE CYCLE TREATMENT; OPEN LUNG BIOPSY; PROGNOSIS; THORAX RADIOGRAPHY; THROMBOCYTOSIS; TRANSBRONCHIAL BIOPSY; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; DOXORUBICIN; FATAL OUTCOME; HUMANS; LYMPHOMATOID GRANULOMATOSIS; MALE; PREDNISONE; TREATMENT FAILURE; VINCRISTINE;

EID: 38049000725     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Liebow AA, Carrington CRB, Friedman PJ. Lymphomatoid granulomatosis. Hum Pathol 1972;3:457-558.
2. Sordillo PP, Epremian B, Koziner B, et al. Lymphomatoid granulomatosis: an analysis of clinical and immunologic characteristics. Cancer 1982;49:2070-6.
3. Fauci AS, Haynes BF, Costa J, et al. Lymphomatoid granulomatosis: prospective clinical and therapeutic experience over 10 years. N Engl J Med 1982;306:68-74.
4. DeRemee RA, Weiland RH, McDonald TJ. Polymorphic reticulosis and lymphomatoid granulomatosis: two diseases or one? Mayo Clin Proc 1978;53:634-40.
5. Jaffe ES. Pathologic and clinical spectrum of post-thymic t-cell malignancies. Cancer Invest 1984;2:413-26.
6. Lipford EH, Margolick JB, Longo JL, et al. Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic t-cell proliferations. Blood 1988;72:1674-81.
7. Nichols PW, Koss M, Levine AM, et al. Lymphomatoid granulomatosis: a T-cell disorder? Am J Med 1982;72:467-71.
8. Pisani RJ, DeRemee RA. Clinical implications of the histopathologic diagnosis of pulmonary lymphomatoid granulomatosis. Mayo Clin Proc 1990;65:151-63.
9. Katzenstein AL Peiper SC. Detection of Epstein-Barr virus genomes in lymphomatoid granulomatosis: analysis of 29 cases by the polymerase chain reaction technique. Mod Pathol 1990;3:435-41.
10. Guinee D, Jaffe E, Kingma D, et al. Pulmonary lymphomatoid granulomatosis. Am J Surg Pathol 1994;18:753-64.
11. Wilson WH, Kingma DW, Raffeld M, et al. Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-α2b. Blood 1996;87:4531-7.
12. Katzenstein AA, Carrington CB, Liebow A. Lymphomatoid granulomatosis: a clinicopathologic study Of 152 cases. Cancer 1979;43:360-73.
13. Koss MN, Hochholzer L, Langloss JM, et al. Lymphomatoid granulomatosis: a clinocopathologic study of 42 patients. Pathology 1986;18:283-8.
14. Teruya-Feldstein J, Jaffe ES, Burd PR, et al. The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease. Blood 1997;90:4099-105.
15. Weinstock DM, Ambrossi GG, Brennan C, et al. Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development. Bone Marrow Transplant 2006;37:539-46.
16. Esser JWJ, Niesters, HCM, Van der Holt B, et al. Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation. Blood 2002;99:4364-9.
17. Greenfield HM, Gharib MI, Turner AJ, et al. The impact of monitoring Epstein-Barr virus PCR in paediatric bone marrow transplant patients: can it successfully predict outcome and guide intervention? Pediatr Blood Cancer 2006;47:200-5.
18. Raez LE, Temple JD, Saldana M. Successful treatment of lymphomatoid granulomatosis using cyclosporine - A after failure of intensive chemotherapy. Am J Hematol 1996;53:192-5.
19. Wilson WH, Gutierrez M, Raffield M, et al. Lymphomatoid granulomatosis: phase II study of dose-adjusted interferon-α or EPOCH chemotherapy [Abstract]. Blood 1999;94(10 Pt1):A-2668, 599a.
20. Richter C, Schnabel A, Müller KM, et al. Lymphomatoide granulomatose - Remissionsinduktion mit interferon-α2b. Dtsch Med Wschr 1997;122:1106-10.
21. Ören H, Irken G, Kargi A, et al. A pediatric case of lymphomatoid granulomatosis with onset after completion of chemotherapy for acute myeloid leukemia. J Pediatr Hematol Oncol 2003;25:163-6.
22. Bernstein ML, Reece ER, de Chadarévian J, et al. Bone marrow transplantation in lymphomatoid granulomatosis: Report of a case. Cancer 1986;58:969-72.
23. Lemieux J, Berbier V, Martel N, et al. Autologous hematopoietic stem cell transplantation for refractory lymphomatoid granulomatosis. Hematology 2002;7:355-8.
24. Johnston A, Coyle L, Nevell D. Prolonged remission of refractory lymphomatoid granulomatosis after autologous hemopoietic stem cell transplantation with post-transplantation maintenance interferon. Leuk Lymphoma 2006;47:323-8.
25. Sebire NJ, Haselden S, Malone M, et al. Isolated EBV lymphoproliferative disease in a child with Wiskott-Aldrich syndrome manifesting as cutaneous lymphomatoid granulomatosis and responsive to anti-CD20 immunotherapy. J Clin Pathol 2003;56:555-7.
26. Zaidi A, Kampalath B, Peltier WL, et al. Successful treatment of systemic and central nervous system lymphomatoid granulomatosis with rituximab. Leuk Lymphoma 2004;45:777-80.
27. Jordan K, Grothey A, Grothe W, et al. Successful treatment of mediastinal lymphomatoid granulomatosis with rituximab monotherapy. Eur J Haematol 2005;74:263-6.
28. Jaffre S, Jardin F, Dominique S, et al. Fatal haemoptysis in a case of lymphomatoid granulomatosis treated with rituximab. Eur Respir J 2006;27:644-6.
29. Polizzotto MN, Dawson MA, Opat SS. Failure of rituximab monotherapy in lymphomatoid granulomatosis. Eur J Haematol 2005;75:172-3.
30. Hochberg EP, Gilman MD, Hasserjian RP. Case 17-2006: A 34-year-old man with cavitary lung lesions. N Engl J Med 2006;354:2485-93.
31. Rao R, Vugman G, Leslie WT, et al. Lymphomatoid ganulomatosis treated with rituximab and chemotherapy. Clin Adv Hematol Oncol 2003;1:658-60.
32. Hagberg H. Review on lymphomatoid granulomatosis treated with rituximab and chemotherapy. Clin Adv Hematol Oncol 2003;1:660.
33. Jaffe ES, Wilson WH. Lymphomatoid granulomatosis: pathogenesis, pathology and clinical implications. Cancer Surv 1997;30:233-48.
34. Coiffier B, Lepage E, Briere J, et al. CHOP Chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-b-cell lymphoma. N Engl J Med 2002;346:235-42.